UK Health Security Agency

gov.uk Imported from official source

UK Health Security Agency — publications from its own official source.

Publications 216

  1. Guidance: Per- and polyfluoroalkyl substances (PFAS): general information

    Information about Per- and polyfluoroalkyl substances also known as PFAS

    Safety 1 document
  2. Research: The health impacts from industrial sources of PFAS: a rapid review

    A rapid review of evidence on the potential adverse health outcomes from long-term exposure to per- and polyfluoroalkyl substances (PFAS) or ‘forever chemicals’.

    Safety 3 documents
  3. Guidance: COVID-19 vaccine (5 years and over) PGD and VGD

    Patient group direction (PGD) and vaccine group direction (VGD) to support the COVID-19 vaccination programme.

    Safety 2 documents
  4. Salmonella outbreak update

    UKHSA, alongside the Food Standards Agency and other public health partners, continues to investigate an outbreak of Salmonella in the UK.

  5. Accredited official statistics: Cover of vaccination evaluated rapidly (COVER) programme: April 2025 to March 2026

    Official statistics annual data on coverage achieved by the childhood immunisation programme in England.

  6. Research: Salmonella statistical releases

    Statistical release in response to cases of Salmonella in England connected to the outbreak likely associated with imported eggs.

  7. Research: Measles, mumps and rubella: lab-confirmed cases in England 2026

    Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Reference Department or local laboratory testing.

  8. Official Statistics: Weekly all-cause mortality surveillance: 2026 to 2027

    How the actual number of deaths in England compare with the expected numbers of deaths for each week.

  9. Guidance: Nipah virus (NiV): biological principles

    Core principles relating to the biology and transmission of Nipah virus.

  10. Research: Meningococcal disease: laboratory-confirmed cases in England 2025 to 2026

    Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.

  11. Research: National Immunisation programme: Health Equity Audit 2025

    The 2025 audit of the National Immunisation programme aligned with the UKHSA Immunisation Equity Strategy 2025 to 2030

  12. Accredited official statistics: Gram-negative, MRSA and MSSA bacteraemia and C. difficile infections: monthly data, 2025 to 2026

    Gram-negative, MRSA and MSSA bacteraemia by organisation and location of onset, and C. difficile infections by organisation and prior trust exposure.

  13. Transparency data: UKHSA spend over £25,000: 2026

    Details of UK Health Security Agency (UKHSA) transactions over £25,000 in 2026.

    8 documents
  14. Transparency data: UKHSA spend over £500: 2026

    Details of UK Health Security Agency (UKHSA) Government Procurement Card (GPC) transactions over £500.

  15. Official Statistics: Respiratory syncytial virus (RSV) maternal vaccination coverage in England

    Official statistics data and reporting on vaccine uptake for the RSV (respiratory syncytial virus) vaccination programme for pregnant women.

  16. Official Statistics: Cold mortality monitoring report, England: winter 2024 to 2025

    Annual report on the surveillance of mortality during cold episodes.

  17. Guidance: Cold mortality monitoring report, England: quality and methodology information

    Outlines the quality and methodology information (QMI) for the cold mortality monitoring reports.

  18. Official Statistics: Respiratory syncytial virus (RSV) older adults vaccination coverage in England

    Vaccine uptake data for the respiratory syncytial virus (RSV) vaccination programme for older adults.

  19. Research: Emergency department: weekly bulletins for 2026

    The number of people going to emergency departments each day, with results published every week under the syndromic surveillance system.

  20. Research: GP in-hours: weekly bulletins for 2026

    Monitors the number of people who visit their GP during surgery hours under the syndromic surveillance system.

  21. Research: Remote health advice: weekly bulletins for 2026

    Summary of the number of people calling NHS 111 for health advice within England on a weekly basis under the syndromic surveillance system.

  22. Research: National ambulance syndromic surveillance: weekly bulletins 2026

    The number of people calling ambulances each day, with results published every week under the syndromic surveillance system.

  23. Research: Syndromic surveillance: weekly summaries for 2026

    This weekly summary highlights changes in the number of people visiting GPs, going to emergency departments and calling NHS 111.

  24. Research: GP out-of-hours syndromic surveillance: weekly bulletins for 2026

    The number of people contacting their GPs outside of surgery hours under the syndromic surveillance system.

  25. Research: Notifiable diseases: causative agents reports for 2026

    Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses (see important note in Details section, below).

    38 documents
  26. Research: Outbreaks under monitoring in 2026

    Latest information on global disease events under monitoring.

  27. Guidance: Referring influenza samples to UKHSA's respiratory virus unit

    How to refer flu samples to UKHSA's respiratory virus unit for diagnosis, subtyping, antiviral resistance testing and surveillance.

  28. Research: Measles: historic confirmed cases, notifications and deaths

    Laboratory-confirmed cases and notifications of measles in England. Deaths apply to England and Wales.

  29. Guidance: Avian influenza: managing human exposures and sporadic cases

    Guidance for the management of individuals exposed to avian influenza, and sporadic human cases and their contacts.

  30. Training and events: UKHSA Knowledge and Library Services

    Knowledge and Library Services provide a range of information skills training for eligible staff. Training is available in group or one-to-one settings.

  31. Services for NHS England public health staff: UKHSA Knowledge and Library Services

    This page details the Knowledge and Library Services (KLS) available to public health staff in NHS England and in Offices for Pan-ICB Commissioning.

  32. Guidance: Pre-release access lists: Tuberculosis in England national quarterly reports

    Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis in England: national quarterly reports.

  33. Guidance: Respiratory syncytial virus (RSV): vaccination for older adults

    Information on respiratory syncytial virus (RSV) and the benefits of vaccination for adults and resources to promote the vaccination to older adults.

  34. Guidance: Pre-release access lists: COVER programme quarterly data

    Lists of those receiving pre-release access to UK Health Security Agency cover of vaccination evaluated rapidly (COVER) programme quarterly data

  35. Guidance: Pre-release access lists: National flu and COVID-19 surveillance reports

    Lists of those receiving pre-release access to UK Health Security Agency 'National flu and COVID-19 surveillance' reports.

  36. Measuring excess mortality: a guide to the main reports

    A guide to the major publications related to excess deaths in the UK, who produces them and links to the methods and analysis.

  37. Corporate report: UKHSA Public Sector Equality Duty (PSED) report

    Report setting out how UKHSA has responded to its equality duties.

  38. Research: Measles epidemiology 2023 to 2026

    Number of laboratory-confirmed cases of measles by age group, region and upper tier local authority from 1 January 2026 onwards.

  39. Research: Hepatitis B in England

    UKHSA hepatitis B virus reports and supporting documents for England.

  40. Research: HIV Action Plan monitoring and evaluation framework

    Public health analysis of progress towards meeting the aims of the HIV Action Plan for England.

  41. Research: Diphtheria: cases among asylum seekers in England, 2022 to 2026

    Tables showing confirmed toxigenic C. diphtheriae cases among asylum seekers in England between 2022 and 2026.

  42. Guidance: Acute respiratory illness in PPDs and the CYPSE

    Managing acute respiratory illness (ARI) in prisons and other prescribed places of detention (PPDs) and in the Children and Young People Secure Estate (CYPSE).

    Safety 2 versions
  43. Guidance: COVID-19 vaccination: autumn programme resources

    Information leaflet and sticker for the COVID-19 autumn vaccination programme.

  44. Public health impact of drought: advice for the public

    Information on the potential health impacts of drought in England and the measures that people can take to stay healthy during these events.

  45. Research: Mpox clade Ib and clade IIb outbreak: epidemiological overview

    The latest information on mpox clade Ib and clade IIb cases in the UK and mpox vaccine administration in England.

  46. UKHSA commercial opportunities

    This guidance is designed to help UKHSA customers and suppliers to navigate engaging and working with us and to signpost upcoming events and opportunities.

    3 documents
  47. Guidance: Accessing UKHSA protected data

    How to apply for access to protected data from UKHSA.

  48. Research: Lead exposure in children: surveillance reports (from 2021)

    Results of laboratory-based surveillance of elevated blood lead concentrations in children in England.

  49. Official Statistics: Tuberculosis in England: national quarterly reports

    The latest quarterly reports of provisional data for tuberculosis (TB) notifications in England.

  50. Guidance: BCG vaccination and SCID screening: patient pathway

    BCG vaccination and SCID screening patient pathway flowchart

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.